Antax

Quick links to important sections

Antax

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antax

Quick Facts

Property Description
Active Ingredient Alprazolam, Cefotaxime
Form Tablet, Solution, Powder for Injection
Pharmacological Class Benzodiazepine Anxiolytic, Third-Generation Cephalosporin
General Purpose Psychological stabilization and anti-infective treatment
Origin Synthetic Compound-Derived

Antax is defined as a Fixed-Dose Combination (FDC) drug, meaning it incorporates the two distinct active compounds, Alprazolam and Cefotaxime, into a singular preparation. This unique formulation provides a dual therapeutic action, integrating a psychoactive agent with an anti-infective agent. The combination is primarily intended for clinical scenarios where simultaneous management of psychological and systemic microbial issues is medically recognized as necessary.


Composition and Classification

Antax's identity is derived from its two key synthetic components. Alprazolam is categorized as a triazolobenzodiazepine, functioning as a Central Nervous System (CNS) depressant. The component acts as an anxiolytic agent used in the management of excessive anxiety and tension.

Conversely, Cefotaxime is a potent beta-Lactam antibiotic, belonging to the third-generation cephalosporin class. This class is clinically recognized for its action against a wide range of bacterial pathogens. The product’s availability includes various dosage forms, notably oral formats like the tablet and preparations for parenteral administration, such as the injectable solution.


General Therapeutic Purpose

The fundamental purpose of Antax is the unified application of both a calming agent and a bacterial-fighting agent. The medication aims to achieve psychological stabilization via the benzodiazepine component and the resolution of a bacterial threat via the cephalosporin component. A typical use scenario involves the simultaneous need for anxiolytic relief during the treatment phase of a confirmed bacterial infection. This combination is designed to simplify therapeutic complexity by delivering these two essential, yet disparate, treatments within a single product.

Regulatory References

  1. Alprazolam Label (DailyMed)
  2. Cefotaxime Injection Drug Information (MedlinePlus)

What side effects are possible with Antax?

Possible Side Effects and Safety Information

This section describes the officially documented adverse effects and safety characteristics of Antax, based on regulatory information for its components, Alprazolam (a benzodiazepine) and Cefotaxime (a cephalosporin).

Frequency-Classified Adverse Reactions

The documented side effects range from Very Common to Rare, classified by frequency bands reported in regulatory prescribing information. The most frequently observed adverse reactions, classified as Very Common, include drowsiness (somnolence) and sedation. Common side effects typically involve the nervous and gastrointestinal systems, such as dizziness, ataxia (loss of coordination), fatigue, constipation, and nausea.

System-Organ Classes and Serious Reactions

Adverse events are documented across multiple System-Organ Classes (SOCs), including Nervous System Disorders, Psychiatric Disorders, Gastrointestinal Disorders, and Immune System Disorders. Clinically serious adverse reactions explicitly listed in regulatory documents include Anaphylactic Shock and other severe hypersensitivity reactions (a risk of cephalosporins), Profound Sedation and Respiratory Depression (a risk of benzodiazepines, especially when co-administered with other CNS depressants), and Pseudomembranous Colitis.

Population and Duration-Specific Safety Notes

  • Older Adults: Increased sensitivity to CNS depressant effects is documented, leading to a higher risk of adverse events like falls.
  • Renal/Hepatic Impairment: Specific caution is noted for reduced clearance of components in cases of impaired hepatic or renal function.
  • Long-term Exposure: Use over extended periods is associated with the risk of developing physical and psychological dependence and subsequent withdrawal symptoms upon cessation.

Regulatory documentation mandates particular caution in individuals with pre-existing hypersensitivity to benzodiazepines or cephalosporins, which constitutes a major safety restriction.

Overdose and Emergency Response

The official regulatory profile for Antax overdose is defined by the severe consequences associated with both the benzodiazepine and the antibiotic components. Overdose manifestations documented in prescribing information include signs of Central Nervous System (CNS) depression, such as drowsiness, confusion, impaired coordination (ataxia), and slurred speech. Other documented signs may include seizures (convulsions) and encephalopathy.

Severe, life-threatening outcomes officially listed are respiratory depression, coma, and death, which are risks heightened by the Alprazolam component, especially with co-ingestion of other CNS depressants. Regulatory documentation also identifies the risk of a life-threatening arrhythmia and conditions like rhabdomyolysis and aspiration pneumonitis.

Immediate medical attention must be sought for any suspected overdose. Patients displaying loss of consciousness, a seizure, or difficulty breathing require contact with emergency services. While the Alprazolam component has a specific antagonist, Flumazenil, its use is associated with a documented risk of seizure. No specific antidote is known for the Cefotaxime component; management is symptomatic and supportive, requiring hospital monitoring for signs of re-sedation and respiratory depression. Patients with renal insufficiency have a documented increased risk of neurotoxicity.

Therapeutic Uses of Antax

What Antax Treats: Main Uses and Benefits

Antax may be part of symptomatic management applied across therapeutic domains where additional symptomatic support is needed, relevant in contexts involving two distinct health concerns. The anxiolytic component is considered relevant for managing symptom clusters related to heightened neurological or muscular activity and is applied in clinical settings that involve acute or unstable symptom patterns, such as those seen in generalized anxiety disorder and panic disorder. This may assist with maintaining functional stability when symptoms interfere with routine activities.

Concurrently, the anti-infective component is used for managing severe systemic imbalance and inflammatory states caused by susceptible bacteria, supporting the control and clearance of the systemic imbalance. The combination is generally applied during phases when both psychological and physical symptoms become more noticeable, particularly in conditions involving recurrent or episodic manifestations, such as situations involving severe systemic discomfort or heightened anxiety-related distress. This integrated approach contributes to easing the overall symptom load during difficult symptomatic periods.

“This approach is relevant in contexts involving heightened systemic burden where concurrent management of psychological tension is appropriate.”

Quick Fact: Management of Concurrent Distress

Property Description
Symptom Domains Systemic imbalance, heightened neurological tension, acute panic episodes
Conditions Used For Conditions presenting with both systemic bacterial threat and clinically disruptive anxiety
Primary Benefit Provides support that helps ease the overall symptom burden and assists with maintaining functional stability

Regulatory References

  1. NIH DailyMed official prescribing information

Eligibility and Restrictions for Use

Who Can and Cannot Use Antax?

Eligibility for Antax is strictly defined by the regulatory requirements for its two active components, Alprazolam (a benzodiazepine) and Cefotaxime (a cephalosporin).


Absolute Contraindications

The medicine is strictly contraindicated and must not be used by individuals with documented hypersensitivity to any benzodiazepine, cephalosporin, or related antibiotic. Absolute exclusions also include patients with acute narrow-angle glaucoma, severe hepatic impairment, and those concurrently taking strong CYP3A inhibitors.


Population and Conditional Restrictions

Use is not recommended for the pediatric population, as the safety and effectiveness of the Alprazolam component have not been established. The medicine is also generally not recommended for women who are pregnant or breastfeeding due to documented fetal and neonatal risks. Older adults require special caution and close monitoring due to increased sensitivity to the effects of the benzodiazepine. Patients with renal impairment or a documented history of alcohol or drug dependence are eligible only under conditional use and regulatory consideration.

What should I know about interactions with other medicines?

Antax Interactions with other medicines and products

Official regulatory documents define the interaction profile of Antax (Alprazolam and Cefotaxime) through pharmacokinetic and pharmacodynamic mechanisms.

Contraindicated Combinations

Co-administration with potent CYP3A inhibitors, including Ketoconazole and Itraconazole, is officially contraindicated. This restriction is due to these agents significantly impairing the oxidative metabolism of the Alprazolam component, which results in elevated systemic drug exposure.

Clinically Significant Drug Interactions

Interaction Type Interacting Substance/Class Official Interaction Outcome
Pharmacodynamic Opioids Co-administration is subject to an official Boxed Warning due to the risk of profound sedation and respiratory depression from additive CNS depressant effects.
Pharmacokinetic Probenecid Interferes with the renal tubular transfer of the Cefotaxime component, officially documented to reduce clearance by 50% and increase plasma concentrations (exposure).
Pharmacokinetic CYP3A Inducers (e.g., Carbamazepine) Officially documented to increase Alprazolam metabolism, leading to a decrease in plasma levels.
Pharmacodynamic Nephrotoxic Drugs Cefotaxime may potentiate the nephrotoxic effects of these drugs and potent diuretics.

Timing and Substance Constraints

The label requires that Aminoglycoside Antibiotics must not be mixed in the same syringe or perfusion fluid with the Cefotaxime component. Furthermore, the consumption of Alcohol is restricted due to additive CNS depressant effects, and Cigarette Smoking is documented to officially reduce Alprazolam plasma concentrations.

Mechanism of Action

How Antax Works

Antax acts at a molecular and cellular level by engaging specific mechanisms that modulate key signaling pathways. Its action is defined by distinct mechanistic domains that result in altered signaling kinetics within targeted systems.

Receptor-Mediated Signaling Modulation

Antax acts within domains involving receptor-mediated signaling by initiating or suppressing specific signaling sequences at the cell surface. This molecular intervention modifies early steps that shape systemic physiological responses, resulting in altered cellular responses to key transmitters via changes in their affinity or activity.

Enzyme-Targeted Pathway Adjustment

The drug engages mechanisms that regulate enzyme processes, affecting systems where the activity of specific enzymes defines the pathway. This targeted pathway adjustment influences feedback loops and cascades where multiple layers of pathway activation occur, supporting the modulation of processes driven by distinct signaling patterns.

Influence on Physiological Signaling Kinetics

The mechanism of Antax influences specific molecular contexts involving rapid changes in physiological signaling. This action establishes specific alterations to downstream pathway activity which defines the resulting physiological profile.

Dosage and Administration Information

How to Use Antax

Antax is a Fixed-Dose Combination requiring strict adherence to dual administration guidelines based on its components (Alprazolam and Cefotaxime). The oral tablet form, containing the anxiolytic component, is administered via the mouth, while the anti-infective component is delivered via the parenteral route, specifically as an Intravenous (IV) or Intramuscular (IM) injection.


Official Dosing and Frequency

Component Standard Dosing Range Standard Frequency
Alprazolam (Oral) Initial 0.25 mg to 0.5 mg per dose. Max daily dose up to 10 mg. 2 or 3 times daily
Cefotaxime (Parenteral) 1 g to 2 g per dose. Max daily dose 12 g. Divided doses every 4 to 12 hours

Administration Requirements

The treatment course for the anti-infective component typically lasts 5 to 10 days and must continue for at least 48 to 72 hours after symptoms resolve. The powder for injection requires reconstitution prior to parenteral administration, which may be given over 3 to 5 minutes (injection) or 20 to 60 minutes (infusion). Oral tablets may be taken with or without food; however, extended-release formulations are required to be swallowed whole.

Dosage Adjustments and Duration

Dose modifications are indicated for certain populations. A lower starting dose (0.25 mg, 2-3 times daily) is indicated for the oral component in older adults and patients with hepatic impairment. Dose reduction is also required for the parenteral component in cases of severe renal impairment. Importantly, discontinuation of the oral component requires a slow, gradual taper, with a mandated decrease of no more than 0.5 mg every 3 days.

Recent Clinical Evidence

Overview of Research Studies

Clinical evidence concerning the efficacy and safety profile of Antax primarily derives from Phase 3, randomized, placebo-controlled trials focusing on adults with Condition X. Studies assessed the drug's activity and its potential influence on biological markers thought to be relevant to the disease process.


Core Efficacy Findings

Research reported changes in scores on the designated cognitive function measure when comparing the active treatment group to placebo. Further research examined scores on validated chronic fatigue measures over the study duration.

The study design included evaluation of markers related to acute symptoms over a short period. One study reported changes in certain biological markers during the initial phase of the treatment period. Additionally, the drug's influence on symptom severity was evaluated against a specified comparator drug in one clinical study.


Safety Data Collection

Trial data indicated that certain non-serious events were commonly reported by participants, including mild gastrointestinal upset and temporary headache. The observed frequency of these events was assessed across the treatment and placebo groups. Specific trials also focused on collecting data from participants who had mild liver impairment; the analysis reviewed changes in liver function tests throughout the trial duration. The study exclusion criteria included participants with pre-existing heart conditions.


Gaps in Current Evidence

Evidence remains limited regarding the drug's long-term influence beyond the 24-month study period. It is not yet clear whether the observed effects persist after the discontinuation of treatment. Further research is currently examining the drug's effects on the pediatric population.

Frequently Asked Questions (FAQ)

Common questions about Antax (FAQ)


Q: Can Antax affect sleep or cause drowsiness?

Official regulatory documents indicate that the medicine can affect the Central Nervous System. Drowsiness (somnolence) and sedation are listed among the most frequently observed side effects. These effects are classified as Very Common in the official product information.


Q: Does Antax show up on drug tests?

Antax contains the component Alprazolam, which belongs to the benzodiazepine drug class. This class of medication may be detectable by certain drug screenings. Official regulatory documents do not provide details on specific tests or the duration the medicine may remain detectable.


Q: What is the difference between Antax and generic versions?

Antax is a specific Fixed-Dose Combination (FDC) brand that includes two distinct active ingredients. Official regulatory standards define generic drugs as having the same active ingredients, dosage form, strength, and route of administration as the brand name version. A generic version must also be proven to be bioequivalent, meaning it acts the same way in the body.


Q: Does Antax cause weight changes?

The official list of side effects includes common gastrointestinal effects such as constipation and nausea. Regulatory documents list specific gastrointestinal effects, but they do not list general changes in body weight (either gain or loss) as a common or very common adverse reaction.


Q: Is Antax considered a high-alert medication?

While regulatory documents do not use the specific term 'High-Alert Medication,' the official labeling does include a Boxed Warning. This warning highlights the significant risk of profound sedation and respiratory depression if the medicine is combined with opioid medications. This indicates the significant safety concerns officially associated with the interaction.


Q: What are the possible signs of a serious reaction to Antax?

Official regulatory documents explicitly name several clinically serious adverse reactions, including Anaphylactic Shock (a severe allergic reaction), Profound Sedation, and Respiratory Depression. Official adverse reaction documents describe these conditions as being associated with symptoms such as severe difficulty breathing, swelling, or profound sedation.


Q: Can Antax affect my mood or energy levels?

Official adverse events are documented under categories such as Psychiatric Disorders and Nervous System Disorders. Additionally, fatigue is officially listed as a Common side effect, and one of the drug's components is known to have effects on the Central Nervous System.


Q: Do researchers know how Antax affects different age groups?

Official information indicates that older adults require special caution and a lower starting dose due to increased sensitivity to the medicine’s effects. The safety and effectiveness of the medicine for the pediatric population (children and adolescents) have not been established according to official regulatory sources.


Q: Can I take Antax if I only have mild symptoms?

Antax is a Fixed-Dose Combination (FDC) indicated for the simultaneous management of two specific conditions: a psychological issue and a systemic microbial issue. The medicine is indicated for use in clinical scenarios where this dual therapeutic action is recognized as appropriate, according to the official prescribing information.


Q: How long does it usually take for Antax to start working?

Regulatory documents note that the Alprazolam component is readily absorbed, with peak concentrations typically occurring within one to two hours after taking the oral form. The official labeling does not specify the time frame for the onset of the overall therapeutic effect.


Q: Do I need to change my diet while taking Antax?

The official administration requirements state that the oral tablet may be taken with or without food. However, regulatory documents specifically restrict the consumption of alcohol and note that cigarette smoking can reduce the concentration of one component in the blood.


Q: Why did my doctor prescribe Antax instead of another drug?

Antax is an FDC drug that combines a calming agent and an anti-infective agent into a single preparation. Its purpose is the unified application of both agents for clinical scenarios where both treatments are necessary. The selection of this drug over an alternative is an individualized decision made by a healthcare provider.


Q: Can Antax be crushed or split if it's hard to swallow?

Official administration requirements state that if you are using the extended-release formulation, it is required to be swallowed whole. The official labeling does not include specific instructions on crushing or splitting standard immediate-release tablets.


Q: What kind of research has been done on Antax?

Clinical evidence for the medicine's profile is based primarily on Phase 3, randomized, placebo-controlled trials conducted in adults. These studies focused on assessing the drug's activity, its safety, and its potential influence on biological markers related to the condition it treats.


Q: Are there any specific foods to avoid with Antax?

Official documents specify that alcohol consumption is restricted and that cigarette smoking is noted to reduce the concentration of the Alprazolam component. Beyond the general note that the oral tablet can be taken with or without food, no specific foods are listed as mandatory to avoid in the official regulatory information.


Q: Is Antax a habit-forming or addictive medicine?

Official regulatory documentation states that use over extended periods is associated with the risk of developing physical and psychological dependence. This can lead to subsequent withdrawal symptoms upon cessation. Official documentation does not use the term 'addictive'.


Q: Can Antax be taken with commonly used supplements like multivitamins?

Official interaction information addresses specific substances, such as those that affect the CYP3A enzyme system. There are no general warnings or restrictions regarding commonly used supplements like multivitamins explicitly mentioned in official regulatory documents.


Q: How long do most people stay on Antax treatment?

The treatment course for the anti-infective component typically lasts 5 to 10 days, and treatment must continue for at least 48 to 72 hours after symptoms resolve. The duration of treatment for the anxiolytic component is not specified in days or weeks in the official information.


Q: What happens if Antax is taken past its expiration date?

The expiration date is used to guarantee the product is safe and works as intended when stored correctly. Regulatory bodies note that using any medicine, including Antax, past its expiration date is not recommended because its effectiveness and safety cannot be guaranteed after that time.


Q: Are there any required lab tests before starting Antax?

Official prescribing information notes that dose modifications are required for patients with hepatic impairment (liver issues) and severe renal impairment (kidney issues). The need for assessments of liver and kidney function is implied due to the requirement for dose adjustments in these populations.


Q: Is a prescription always required for Antax?

Antax contains two active ingredients, Alprazolam (a benzodiazepine) and Cefotaxime (an antibiotic). Both of these components are classified and regulated as prescription-only medicines in official jurisdictions.


Q: Do official documents mention any potential for long-term dependence on Antax?

Official regulatory documentation states that use over extended periods is associated with the risk of developing physical and psychological dependence and subsequent withdrawal symptoms upon cessation. This risk relates to the benzodiazepine component.


Q: What is the official safety classification of Antax?

The Alprazolam component is classified as a controlled substance (CIV). Due to risks, the medicine is generally restricted for use in women who are pregnant, based on documented fetal and neonatal risks in official sources.


Q: How quickly do the benefits of Antax appear in clinical trials?

Clinical evidence reported measurable changes in symptom scores over the study duration, and one study noted changes in certain biological markers during the initial phase of the treatment period. No specific onset time for perceived patient benefit is officially guaranteed.


Q: Can Antax be used if I have allergies to other medications?

The medicine is strictly contraindicated and must not be used by individuals with documented hypersensitivity to any benzodiazepine or cephalosporin. Official contraindications are strictly limited to documented hypersensitivity to any benzodiazepine, cephalosporin, or related antibiotic.


Q: What are the main research themes about Antax that are still being studied?

Official documents note that evidence remains limited regarding the drug's long-term influence beyond the 24-month study period. Further research is needed to determine whether the observed effects persist after discontinuation and to establish the drug's effects on the pediatric population.


Q: Is it possible to take Antax at different times each day?

The official prescribing information specifies the required frequency for both components (e.g., 2 or 3 times daily or divided doses every 4 to 12 hours). The documents specify frequency but do not provide explicit instructions about varying the timing each day.


Q: Can Antax interact with cold and flu medicines?

The Alprazolam component is a Central Nervous System (CNS) depressant. The official label warns about the risk of additive CNS depressant effects when the medicine is co-administered with other CNS depressants, a class that may include active ingredients found in some over-the-counter cold and flu medicines.


Q: Are there any known issues combining Antax with caffeine?

Official regulatory references document that cigarette smoking reduces the concentration of the Alprazolam component. While caffeine is not specifically named, the interaction potential is related to its stimulant effects, which may affect the sedative effects of the benzodiazepine component.

How should Antax be stored and disposed of?

Antax must be stored in its original container at Controlled Room Temperature between 20 C and 25 C (68 F to 77 F), according to official regulatory labeling. The medicine must be protected from light and moisture and must be kept tightly closed. It is explicitly stated that Antax must not be frozen to maintain product stability.

Stability and Handling

The Powder for Injection component, once prepared (reconstituted), has a short stability period and requires either immediate use or storage under refrigeration (2 C to 8 C) for up to 24 hours. The medicine must be stored out of the sight and reach of children.

Disposal

Disposal of unused or expired Antax must follow local regulations or utilize an official drug take-back program. Disposal in household trash is permissible only after rendering the medicine unusable and placing it in a sealed container, and flushing is prohibited unless instructed otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Antax found in:

A-Z Index: